Bexion Pharmaceuticals, Inc. announced the appointment of Tariq Arshad, MD, MBA as Chief Medical Officer, bringing his extensive experience in strategic planning, clinical development, and commercialization to the company.

Bexion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to developing a new generation of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN). The company's mission includes potential portfolio expansion opportunities in other cancers and broader neuropathic pain indications.

https://www.bexionpharma.com/

Biopharma

Therapeutics

Pharmaceutical

Bexion Pharmaceuticals Appoints Tariq Arshad As Chief Medical Officer

Bexion Pharmaceuticals Appoints Tariq Arshad As Chief Medical Officer

Company Info

Related People

Unlock Verified Contacts + AI Outreach